Erwinaze and Soliris

• Generic Name: asparaginase erwinia chrysanthemi
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Erwinaze

Erwinaze is an injectable medicine containing asparaginase Erwinia chrysanthemi. Asparaginase is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Erwinaze is used to treat acute lymphocytic lymphoma.

Erwinaze may also be used for other purposes not listed in this medication guide.

• Generic Name: eculizumab
• Dosage Forms: injection, solution, concentrate
• Other Brand Names: Soliris

Soliris (eculizumab) is a monoclonal antibody. Eculizumab binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells.

Soliris is used to prevent the breakdown of red blood cells in adults with paroxysmal nocturnal hemoglobinuria (PNH).

Soliris is also used to treat a rare chronic blood disease called atypical hemolytic uremic syndrome (aHUS) in adults and children who weigh at least 11 pounds (5 kilograms).

Soliris is also used to treat myasthenia gravis in adults.

Soliris is also used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults.

Soliris is available only under a special program. You must be registered in the program and understand the risks and benefits of this medicine.